Aberdeen Group plc trimmed its holdings in shares of Paychex, Inc. (NASDAQ:PAYX – Free Report) by 3.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 239,560 shares of the business services provider’s stock after selling 7,355 shares during the quarter. Aberdeen Group plc owned 0.07% of Paychex worth $26,874,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vista Investment Partners LLC boosted its position in shares of Paychex by 0.8% during the fourth quarter. Vista Investment Partners LLC now owns 26,919 shares of the business services provider’s stock worth $3,020,000 after buying an additional 211 shares during the period. Blue Trust Inc. lifted its stake in Paychex by 5.9% during the 4th quarter. Blue Trust Inc. now owns 3,425 shares of the business services provider’s stock worth $384,000 after acquiring an additional 191 shares in the last quarter. Applied Capital LLC FL purchased a new position in Paychex during the 4th quarter valued at about $1,010,000. Fulcrum Capital LLC boosted its holdings in Paychex by 13.1% during the 4th quarter. Fulcrum Capital LLC now owns 2,745 shares of the business services provider’s stock valued at $308,000 after acquiring an additional 317 shares during the period. Finally, Jamison Private Wealth Management Inc. grew its position in Paychex by 3.1% in the 4th quarter. Jamison Private Wealth Management Inc. now owns 50,886 shares of the business services provider’s stock valued at $5,708,000 after acquiring an additional 1,553 shares in the last quarter. 83.47% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes Several analysts have recently issued reports on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Paychex in a research report on Monday, December 29th. Guggenheim assumed coverage on shares of Paychex in a report on Thursday, March 19th. They issued a “neutral” rating for the company. Citigroup cut their target price on shares of Paychex from $120.00 to $99.00 and set a “neutral” rating on the stock in a research note on Thursday, March 26th. Stephens decreased their price target on shares of Paychex from $125.00 to $105.00 and set an “equal weight” rating for the company in a research report on Thursday, March 26th. Finally, Wolfe Research decreased their target price on Paychex from $130.00 to $115.00 and set an “underperform” rating for the company in a report on Wednesday, December 10th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, twelve have assigned a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Reduce” and an average target price of $108.81.
Get Our Latest Stock Analysis on PAYX
Paychex Stock Performance PAYX opened at $91.70 on Monday. Paychex, Inc. has a one year low of $86.89 and a one year high of $161.24. The company has a market cap of $32.86 billion, a P/E ratio of 20.20 and a beta of 0.88. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.26 and a current ratio of 1.26. The business’s 50-day simple moving average is $95.05 and its 200-day simple moving average is $109.18.
Paychex (NASDAQ:PAYX – Get Free Report) last issued its earnings results on Wednesday, March 25th. The business services provider reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.67 by $0.04. The business had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.78 billion. Paychex had a return on equity of 48.52% and a net margin of 25.84%.The business’s quarterly revenue was up 19.9% on a year-over-year basis. During the same quarter last year, the company earned $1.49 EPS. As a group, equities research analysts expect that Paychex, Inc. will post 4.99 EPS for the current fiscal year.
Paychex Announces Dividend The business also recently announced a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Wednesday, January 28th were issued a $1.08 dividend. The ex-dividend date was Wednesday, January 28th. This represents a $4.32 annualized dividend and a dividend yield of 4.7%. Paychex’s dividend payout ratio is presently 95.15%.
Paychex announced that its Board of Directors has authorized a share buyback plan on Friday, January 16th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the business services provider to buy up to 2.5% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s management believes its shares are undervalued.
About Paychex (Free Report)
Paychex, Inc, founded in 1971 by B. Thomas “Tom” Golisano and headquartered in Rochester, New York, is a provider of payroll, human resources, and benefits outsourcing solutions for small- and medium-sized businesses. The company’s core services include payroll processing and tax filing, employee benefits administration, retirement services, and workers’ compensation administration, designed to simplify back-office operations and help clients comply with regulatory and tax requirements.
Paychex offers an integrated technology platform, marketed under the Paychex Flex brand, which delivers cloud-based payroll, HR, time and attendance, and reporting tools.
Read More Five stocks we like better than Paychex Want to see what other hedge funds are holding PAYX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Paychex, Inc. (NASDAQ:PAYX – Free Report).
Receive News & Ratings for Paychex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paychex and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAberdeen Group plc Sells 28,289 Shares of Arch Capital Group Ltd. $ACGL
NEXT HEADLINE »Aberdeen Group plc Purchases 5,443 Shares of Targa Resources, Inc. $TRGP
Paychex (NASDAQ:PAYX – Get Free Report) and Cellebrite DI (NASDAQ:CLBT – Get Free Report) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends.
Risk and Volatility Paychex has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.
Earnings & Valuation This table compares Paychex and Cellebrite DI”s revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Paychex $5.57 billion 5.91 $1.66 billion $4.54 20.23 Cellebrite DI $475.68 million 7.39 $78.33 million $0.31 45.48 Paychex has higher revenue and earnings than Cellebrite DI. Paychex is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.
Profitability This table compares Paychex and Cellebrite DI’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Paychex 25.84% 48.52% 11.54% Cellebrite DI 16.47% 20.43% 10.64% Institutional and Insider Ownership 83.5% of Paychex shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 0.8% of Paychex shares are held by insiders. Comparatively, 5.7% of Cellebrite DI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Analyst Ratings This is a summary of current recommendations for Paychex and Cellebrite DI, as provided by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Paychex 4 12 1 1 1.94 Cellebrite DI 1 0 4 0 2.60 Paychex currently has a consensus target price of $108.81, suggesting a potential upside of 18.47%. Cellebrite DI has a consensus target price of $22.50, suggesting a potential upside of 59.57%. Given Cellebrite DI’s stronger consensus rating and higher probable upside, analysts plainly believe Cellebrite DI is more favorable than Paychex.
Summary Paychex beats Cellebrite DI on 8 of the 15 factors compared between the two stocks.
About Paychex (Get Free Report)
Paychex, Inc., together with its subsidiaries, provides integrated human capital management solutions (HCM) for payroll, benefits, human resources (HR), and insurance services for small to medium-sized businesses in the United States, Europe, and India. It offers payroll processing services; payroll tax administration services; employee payment services; and regulatory compliance services, such as new-hire reporting and garnishment processing. The company also provides HR solutions, including integrated HCM technology solutions and HR advisory services through both virtual and on-site availability of a professionally trained HR representative, as well as HR support to non-payroll clients through its HR Partner Plus solution; and retirement services administration, such as plan implementation, ongoing compliance with government regulations, employee and employer reporting, participant and employer online access, electronic funds transfer, and other administrative services. In addition, it offers cloud-based HR administration software products for employee benefits management and administration, time and attendance, digital communication solutions, recruiting, and onboarding solutions; plan administration outsourcing and state unemployment insurance services; various business services to small to medium-sized businesses comprising payroll funding and outsourcing services, which include payroll processing, invoicing, and tax preparation; and payment processing services, financial fitness programs, and a small-business loan resource center. Further, the company provides insurance services for property and casualty coverage, such as workers’ compensation, business-owner policies, cyber security protection, and commercial auto, as well as health and benefits coverage, including health, dental, vision, and life. It markets and sells its services primarily through its direct sales force. The company was founded in 1971 and is headquartered in Rochester, New York.
About Cellebrite DI (Get Free Report)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.
Receive News & Ratings for Paychex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paychex and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAnalyzing G4S (OTCMKTS:GFSZY) and Digimarc (NASDAQ:DMRC)
NEXT HEADLINE »Kratos Defense & Security Solutions (NASDAQ:KTOS) Stock Price Up 10.1% After Analyst Upgrade
Paychex is reaffirmed as a 'Buy,' with accelerating organic growth and strong execution post-Paycor acquisition. PAYX's Q3 2026 revenue grew 19.9% YoY, driven by Paycor synergies and robust cross-selling, with organic growth ramping to 6%. Shares trade at a steep 36% discount to fair value, with a forward P/E of 15.9 vs. a revised fair value multiple of 25.
On April 13, 2026, Paychex Inc (PAYX) shares rose 4.4% today, bringing the current price to $89.32. The stock has experienced a 52-week range of $85.45 to $161.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
#1 (Strong Buy) stocks have produced an unmatched +23.93% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Paychex (PAYX - Free Report) Paychex, Inc. is one of the leading providers of integrated human capital management (“HCM”) solutions for payroll, human resource (“HR”), retirement and insurance services for small- to medium-sized businesses. The company was incorporated in Delaware in 1979.
PAYX is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.
Momentum investors should take note of this Computer and Technology stock. PAYX has a Momentum Style Score of B, and shares are up 0.5% over the past four weeks.
Six analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.01 to $5.50 per share. PAYX also boasts an average earnings surprise of +1.3%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, PAYX should be on investors' short list.
Lbp Am Sa grew its position in shares of Paychex, Inc. (NASDAQ:PAYX – Free Report) by 125.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 40,517 shares of the business services provider’s stock after purchasing an additional 22,527 shares during the quarter. Lbp Am Sa’s holdings in Paychex were worth $4,545,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also made changes to their positions in the company. Vermillion & White Wealth Management Group LLC purchased a new stake in shares of Paychex in the third quarter valued at about $27,000. Stance Capital LLC acquired a new position in Paychex during the third quarter worth about $31,000. MMA Asset Management LLC purchased a new stake in shares of Paychex in the third quarter valued at about $32,000. Board of the Pension Protection Fund purchased a new stake in shares of Paychex in the fourth quarter valued at about $34,000. Finally, Westfuller Advisors LLC purchased a new stake in shares of Paychex in the third quarter valued at about $35,000. 83.47% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In PAYX has been the topic of several recent analyst reports. Citigroup reduced their price objective on shares of Paychex from $120.00 to $99.00 and set a “neutral” rating on the stock in a research note on Thursday, March 26th. Robert W. Baird dropped their price objective on shares of Paychex from $148.00 to $125.00 and set a “neutral” rating for the company in a research report on Thursday, March 26th. Argus raised shares of Paychex to a “strong-buy” rating in a research report on Friday, March 27th. Jefferies Financial Group dropped their price objective on shares of Paychex from $110.00 to $105.00 and set a “hold” rating for the company in a research report on Thursday, March 26th. Finally, Royal Bank Of Canada dropped their price objective on shares of Paychex from $125.00 to $102.00 and set a “sector perform” rating for the company in a research report on Thursday, March 19th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Paychex currently has a consensus rating of “Reduce” and an average price target of $106.38.
Get Our Latest Analysis on PAYX
Paychex Trading Down 0.2% Paychex stock opened at $91.96 on Friday. The firm’s 50-day moving average is $92.76 and its 200-day moving average is $106.74. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.26 and a current ratio of 1.26. Paychex, Inc. has a 1 year low of $85.45 and a 1 year high of $161.24. The company has a market cap of $32.95 billion, a P/E ratio of 20.26 and a beta of 0.88.
Paychex (NASDAQ:PAYX – Get Free Report) last posted its quarterly earnings results on Wednesday, March 25th. The business services provider reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.67 by $0.04. The company had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.78 billion. Paychex had a net margin of 25.84% and a return on equity of 48.52%. The company’s revenue for the quarter was up 19.9% on a year-over-year basis. During the same period last year, the firm posted $1.49 EPS. On average, equities analysts expect that Paychex, Inc. will post 4.99 earnings per share for the current year.
Paychex declared that its Board of Directors has initiated a stock buyback program on Friday, January 16th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the business services provider to buy up to 2.5% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.
Paychex Company Profile (Free Report)
Paychex, Inc, founded in 1971 by B. Thomas “Tom” Golisano and headquartered in Rochester, New York, is a provider of payroll, human resources, and benefits outsourcing solutions for small- and medium-sized businesses. The company’s core services include payroll processing and tax filing, employee benefits administration, retirement services, and workers’ compensation administration, designed to simplify back-office operations and help clients comply with regulatory and tax requirements.
Paychex offers an integrated technology platform, marketed under the Paychex Flex brand, which delivers cloud-based payroll, HR, time and attendance, and reporting tools.
Featured Stories Five stocks we like better than Paychex Want to see what other hedge funds are holding PAYX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Paychex, Inc. (NASDAQ:PAYX – Free Report).
Receive News & Ratings for Paychex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paychex and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINELbp Am Sa Sells 49,033 Shares of Howmet Aerospace Inc. $HWM
NEXT HEADLINE »Lbp Am Sa Has $4.09 Million Stock Position in Coca-Cola Europacific Partners $CCEP
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.93% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Paychex (PAYX - Free Report) Paychex, Inc. is one of the leading providers of integrated human capital management (“HCM”) solutions for payroll, human resource (“HR”), retirement and insurance services for small- to medium-sized businesses. The company was incorporated in Delaware in 1979.
PAYX is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.
Additionally, the company could be a top pick for growth investors. PAYX has a Growth Style Score of B, forecasting year-over-year earnings growth of 10.4% for the current fiscal year.
Six analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.01 to $5.50 per share. PAYX boasts an average earnings surprise of +1.3%.
With a solid Zacks Rank and top-tier Growth and VGM Style Scores, PAYX should be on investors' short list.
A month has gone by since the last earnings report for Paychex (PAYX - Free Report) . Shares have lost about 2.8% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Paychex due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Paychex, Inc. before we dive into how investors and analysts have reacted as of late.
Paychex's Q3 Earnings Beat EstimatesPaychex reported impressive third-quarter fiscal 2026 results, with both earnings and revenues beating the Zacks Consensus Estimate.
PAYX’s fiscal third-quarter earnings of $1.71 per share beat the Zacks Consensus Estimate by 1.8% and increased 14.8% from the year-ago quarter. Total revenues came in at $1.80 billion, surpassing the consensus estimate by 1.4% and increasing 19.9% from the year-ago quarter.
PAYX’s Quarterly PerformanceRevenues from the Management Solutions segment improved 23% year over year to $1.35 billion, meeting our estimate.
Professional employer organization (“PEO”) and Insurance Solutions’ revenues were $397.5 million, increasing 9% from the year-ago quarter. The figure surpassed our estimate of $392.8 million.
Service revenues rose 20% year over year to $1.75 billion, beating our estimated figure of $1.74 billion. Interest on funds held for clients grew 33% from the year-ago quarter to $56.8 million, beating our projection of $45.8 million.
EBITDA of $902.9 million increased 23% from the year-ago quarter, exceeding our estimate of $888.9 million. Operating income rose 14% year over year to $792 million, surpassing our forecast of $775.1 million. The operating margin was 43.8%, down 200 basis points from the year-ago quarter. The reported figure beat our estimate of 43.3%.
Balance Sheet & Cash Flow of PaychexThe company exited the third quarter of fiscal 2026 with cash and cash equivalents of $1.74 billion compared with $1.48 billion in the preceding quarter. Long-term debt totaled $4.55 billion, flat compared with the preceding quarter.
Cash generated from operating activities amounted to $812.5 million, while capital expenditure was $51 million.
PAYX’S Updated FY’26 GuidancePaychex expects revenues to grow 16.5% to 18.5%. Management expects interest on funds held for clients in the range of $200-$210 million.
Adjusted earnings of 99 cents per share beat the Zacks Consensus Estimate by 4.2% and increased 8.8% on a year-over-year basis. Total revenues of $1.2 billion also beat the Zacks Consensus Estimate by 0.5% and increased 7.4% year over year.
Revenues in Detail
Revenues from Management Solutions segment increased 8% year over year to $895.3 million. The segment benefited from growth in the number of client employees served for human capital management (HCM) and additional worksite employees for HR Solutions. Also, improved revenue per client on price realization and higher product penetration, strong demand for HR Solutions, retirement, time and attendance solutions and expansion of HCM ancillary services acted as tailwinds.
Professional employer organization (“PEO”) and Insurance Solutions’ revenues were $273.3 million, up 4% from the year-ago quarter’s level. The uptick was owing to growth in the number of average worksite employees. Interest on funds held for clients increased 54% year over year to $21.7 million.
Operating Performance
Operating income increased 7% year over year to $472.3 million. EBITDA of $518.6 million increased 4.7% year over year.
Balance Sheet & Cash Flow
Paychex exited second-quarter fiscal 2022 with cash and cash equivalents of $1.1 billion compared with $1.18 billion reported at the end of the prior quarter. Long-term debt was $797.9 million compared with $797.8 million in the prior quarter. Cash provided by operating activities was $321.6 million in the reported quarter. During the reported quarter, PAYX paid out $284.7 million as dividends.
Fiscal 2023 View Tweaked
Paychex upped its adjusted earnings per share view with respect to year-over-year growth for fiscal 2023. Adjusted EPS is now expected to register 12-14% growth compared with the prior expectation of 11-12% growth. PAYX continues to expect total revenues to register 8% (prior view: 7-8%) growth. Management Solutions’ revenues are expected to grow 7-8% (prior view: 5-7%). PEO and Insurance Solutions’ revenues are expected to grow 5-7% (prior view: 8-10%).
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates review.
VGM ScoresCurrently, Paychex has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with a D. Charting a somewhat similar path, the stock has a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Paychex has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerPaychex belongs to the Zacks Internet - Software industry. Another stock from the same industry, Rubrik, Inc. (RBRK - Free Report) , has gained 7.2% over the past month. More than a month has passed since the company reported results for the quarter ended January 2026.
Rubrik, Inc. reported revenues of $377.68 million in the last reported quarter, representing a year-over-year change of +46.3%. EPS of $0.04 for the same period compares with -$0.18 a year ago.
For the current quarter, Rubrik, Inc. is expected to post a loss of $0.03 per share, indicating a change of +80% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Rubrik, Inc.. Also, the stock has a VGM Score of C.
Comerica Bank increased its stake in Paychex, Inc. (NASDAQ:PAYX – Free Report) by 10.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 121,705 shares of the business services provider’s stock after acquiring an additional 11,497 shares during the period. Comerica Bank’s holdings in Paychex were worth $13,653,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vermillion & White Wealth Management Group LLC purchased a new position in Paychex in the third quarter worth $27,000. Stance Capital LLC purchased a new position in Paychex in the third quarter worth $31,000. MMA Asset Management LLC purchased a new position in Paychex in the third quarter worth $32,000. Board of the Pension Protection Fund purchased a new position in Paychex in the fourth quarter worth $34,000. Finally, Westfuller Advisors LLC purchased a new position in Paychex in the third quarter worth $35,000. 83.47% of the stock is currently owned by hedge funds and other institutional investors.
Paychex Stock Performance Shares of NASDAQ:PAYX opened at $90.99 on Wednesday. The company has a market cap of $32.60 billion, a price-to-earnings ratio of 20.04 and a beta of 0.88. The company has a 50-day moving average price of $92.27 and a 200-day moving average price of $104.82. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.13. Paychex, Inc. has a 12 month low of $85.45 and a 12 month high of $161.24.
Paychex (NASDAQ:PAYX – Get Free Report) last issued its quarterly earnings data on Wednesday, March 25th. The business services provider reported $1.71 EPS for the quarter, beating the consensus estimate of $1.67 by $0.04. The firm had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.78 billion. Paychex had a net margin of 25.84% and a return on equity of 48.52%. The company’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.49 earnings per share. As a group, equities analysts anticipate that Paychex, Inc. will post 5.5 EPS for the current year.
Paychex declared that its board has initiated a share buyback program on Friday, January 16th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the business services provider to repurchase up to 2.5% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board of directors believes its shares are undervalued.
Analyst Upgrades and Downgrades PAYX has been the subject of several research reports. Royal Bank Of Canada cut their target price on shares of Paychex from $125.00 to $102.00 and set a “sector perform” rating for the company in a research report on Thursday, March 19th. BMO Capital Markets upped their price target on shares of Paychex to $52.00 and gave the company an “outperform” rating in a research report on Thursday, March 26th. Morgan Stanley cut their price target on shares of Paychex from $123.00 to $107.00 and set an “equal weight” rating for the company in a research report on Thursday, March 26th. Stephens cut their price target on shares of Paychex from $125.00 to $105.00 and set an “equal weight” rating for the company in a research report on Thursday, March 26th. Finally, Jefferies Financial Group cut their price target on shares of Paychex from $110.00 to $105.00 and set a “hold” rating for the company in a research report on Thursday, March 26th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Reduce” and a consensus price target of $106.38.
Check Out Our Latest Research Report on PAYX
Paychex Company Profile (Free Report)
Paychex, Inc, founded in 1971 by B. Thomas “Tom” Golisano and headquartered in Rochester, New York, is a provider of payroll, human resources, and benefits outsourcing solutions for small- and medium-sized businesses. The company’s core services include payroll processing and tax filing, employee benefits administration, retirement services, and workers’ compensation administration, designed to simplify back-office operations and help clients comply with regulatory and tax requirements.
Paychex offers an integrated technology platform, marketed under the Paychex Flex brand, which delivers cloud-based payroll, HR, time and attendance, and reporting tools.
Read More Five stocks we like better than Paychex
Receive News & Ratings for Paychex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paychex and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEComerica Bank Buys 5,958 Shares of iShares S&P Small-Cap 600 Value ETF $IJS
NEXT HEADLINE »Comerica Bank Sells 9,639 Shares of IDEXX Laboratories, Inc. $IDXX
ROCHESTER, N.Y.--(BUSINESS WIRE)--Paychex, Inc. (Nasdaq: PAYX), an industry-leading human capital management ("HCM") company, today announced that its Board of Directors has declared a regular quarterly cash dividend on Paychex common stock of $1.19 per share, an increase of $0.11 (or 10%) from the prior quarterly dividend of $1.08 per share, payable on May 29, 2026 to shareholders of record as of May 13, 2026.
“Our decision to raise the dividend by 10%—our fifth consecutive double-digit increase—demonstrates our commitment to balanced capital allocation and underscores our confidence in the company’s financial strength and durable business model," said John Gibson, President and CEO of Paychex. "We are committed to delivering long-term shareholder value by strategically investing in opportunities that drive sustainable growth."
For the fiscal year ending on May 31, 2026, Paychex expects to return over $1.5 billion in dividends to shareholders, continuing a tradition of paying consecutive quarterly cash dividends every year since 1988.
About Paychex
Paychex, Inc. (Nasdaq: PAYX) is the digitally driven HR leader that is reimagining how companies address the needs of today’s workforce with the most comprehensive, flexible, and innovative HCM solutions for organizations of all sizes. Offering a full spectrum of HR advisory and employee solutions, Paychex pays 1 out of every 11 American private sector workers and is raising the bar in HCM for approximately 800,000 customers in the U.S. and Europe. Every member of the Paychex team is committed to fulfilling the company’s purpose of helping businesses succeed. Visit paychex.com to learn more.
ROCHESTER, N.Y.--(BUSINESS WIRE)---- $PAYX #employmenttrends--The pace of job growth among U.S. small businesses showed an increase in April, marking the second consecutive month of gains as employers continued to demonstrate resilience amid ongoing economic uncertainty, according to the latest Paychex Small Business Employment Watch. The national jobs index, which reflects employment growth in U.S. small businesses with fewer than 50 employees, rose 0.35 percentage points from March to April (99.16), the largest one‑mont.
Paychex launches groundbreaking agentic AI platform that seamlessly anticipates, advises, and acts across HCM workflows, backed by trusted expertise
Unlike other SMB HCM providers, WISE moves beyond a single agent to a proactive digital workforce that executes autonomously within customer-defined workflows WISE is the intelligence layer across Paychex Flex®, Paycor®, and SurePayroll platforms, spanning AI agents, expert advisory, embedded intelligence, and personal assistants ROCHESTER, N.Y.--(BUSINESS WIRE)--Paychex, Inc. (Nasdaq: PAYX), an industry-leading human capital management (HCM) company, today announced Workforce Intelligence Strengthened by Expertise (WISE), the AI-powered intelligence solution transforming business operations with embedded context-aware intelligence, expert-enabled guidance, and autonomous execution. With Paychex’s five decades of trusted data and human expertise at its core, WISE transforms AI from a passive tool to expert-designed agentic workflows with the ability to complete tasks autonomously, making work faster, smarter, and more efficient.
“AI is integral to our growth strategy, and WISE is the next frontier of AI-enabled solutions for Paychex,” said John Gibson, Paychex president and CEO. “Unlike other SMB HCM providers, WISE goes beyond customer support chatbots and is embedded across our expert-enabled technology, anticipating issues and surfacing recommendations to users in the flow of work. Built on a foundation of decades of data, HR and compliance expertise, and trust, we developed WISE to help businesses of all sizes deploy a digital workforce that augments repetitive tasks, enabling people to focus on more strategic work.”
WISE Natively Available Across Paychex Platforms, Scaling Trusted Expertise
As the shared intelligence platform fueling Paychex’s HR and advisory solutions, WISE utilizes decades of proprietary data, regulatory requirements, and human expertise to power people and performance.
“WISE represents a fundamental shift in how intelligence is applied in HR—from user-directed tools to an agentic platform that works proactively on behalf of customers,” said Ryan Bergstrom, Chief Product Officer at Paychex. “Working collaboratively alongside users for a human in the loop experience that reduces risk and effort, WISE anticipates what matters and proactively takes action autonomously within customer-defined protocols rather than requiring users to search for answers, navigate complex workflows, or react to problems after they occur.”
WISE Combines Intelligence, Multi-Channel Assistants, and Autonomous Agents
WISE strategically underpins Paychex’s approach to powering people and performance through:
Agents: Autonomous digital workers capable of reasoning, orchestrating processes, and executing tasks to move work forward. WISE Agents act within parameters set and controlled by the customer, ensuring employers remain in the driver's seat. In addition to delivering meaningful improvements in customer service responsiveness and speed, agents can intelligently schedule shifts and approve timesheets to help streamline and improve manager productivity and worker efficiency. Intelligence: A context-aware intelligence layer that understands how customers work, what matters most, and when action is needed. Customers utilize WISE Intelligence with HR reporting and predictive analytics that serve actionable insights from real-time data to support workforce planning and decisions. Assistants: Personalized, multi-channel guidance and task support delivered across chat, voice, email, text, and collaboration tools. Customers utilize WISE Assistants for task completion, information retrieval, and regulatory compliance support. Advisory: Complementing experienced advisors with intelligent systems, WISE proactively alerts Paychex HR experts when a critical moment is on the horizon and enables the experienced advisors to guide customers through complex decisions like managing flight risk and drive outcomes that fuel business success. Learn more about how WISE supports Paychex Flex, Paycor, and SurePayroll in automating routine tasks, delivering personalized experiences, and uncovering actionable insights at scale.
About Paychex
Paychex, Inc. (Nasdaq: PAYX) is the digitally driven HR leader that is reimagining how companies address the needs of today’s workforce with the most comprehensive, flexible, and innovative HCM solutions for organizations of all sizes. Offering a full spectrum of HR advisory and employee solutions, Paychex pays 1 out of every 11 American private sector workers and is raising the bar in HCM for approximately 800,000 customers in the U.S. and Europe. Every member of the Paychex team is committed to fulfilling the company’s purpose of helping businesses succeed. Visit paychex.com to learn more.
Key Takeaways Paychex shares rose 7.9% in a month, outperforming the industry's 2.3% decline.PAYX sees strong demand for SaaS, PEO services and AI-powered HCM tools driving its growth.PAYX expanded Paychex Perks and added AI tools to simplify employee benefits selection. Shares of Paychex (PAYX - Free Report) have had a decent run over the past month. The stock has risen 7.9% against the industry's 2.3% decline. The Zacks S&P 500 composite gained 4.5% during the said time frame.
The company’s fourth-quarter fiscal 2026 earnings are expected to increase 10.9% year over year. The company’s fiscal 2026 and 2027 earnings are projected to rise 10.4% and 7.4%, respectively. Revenues are expected to grow 16.9% in fiscal 2026 and 5.9% in fiscal 2027.
Factors That Bode Well for PAYXPaychex’s growth is strongly driven by rising demand for Software-as-a-Service (SaaS) solutions, providing strong momentum across the company’s management solutions and Professional Employer Organization (PEO) segments. Small businesses are increasingly relying on PAYX’s PEO services to provide competitive benefits packages comparable to larger enterprises, helping them attract and retain talent in a tight labor market.
The company also highlighted growing traction for its Paychex Perks, a digital benefits marketplace, in the last reported quarter. Recently, the platform expanded to more than 25 benefit offerings and attracted nearly 350,000 unique employee purchasers. PAYX introduced AI-driven benefits intelligence tools to recommend benefit plans and simplify the selection process by using employee-specific data during enrollment season.
PAYX’s Paychex Flex, an all-in-one solution for human resource payroll, time, and attendance and benefits, and Paycor, a provider of Human Capital Management (HCM), payroll and talent software platforms, were recently recognized as industry-leading HCM solutions with two prestigious 2026 Lighthouse Tech Awards. This reflects the company’s emphasis on AI-powered HCM innovation.
The company currently has more than 500 AI-powered capabilities and agents across its workflows, driving higher productivity and smarter outcomes. These generative AI tools are helping clients and HR professionals manage wage laws, compliance obligations, payroll processing and employee benefits decisions more efficiently.
Risks to WatchPaychex operates in a highly competitive industry with both large and niche players, putting constant pressure on it to innovate and differentiate its offerings while maintaining cost efficiency. This increases the difficulty of balancing growth and profitability.
PAYX’s offerings require it to collect, use and retain a huge amount of personal and financial information from its employees, customers and clients, exposing it to highly sensitive cyberattacks. The company experienced a breach in March 2024, resulting in the unauthorized disclosure of personal data. Such incidents may affect investors’ sentiments.
Zacks Rank & Stocks to Consider
PAYX currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
A couple of better-ranked stocks in the industry are Arista Networks, Inc. (ANET - Free Report) and Docusign, Inc. (DOCU - Free Report) .
Arista Networks carries a Zacks Rank #2 (Buy) at present. It has a long-term earnings growth expectation of 19.9%.
ANET beat the Zacks Consensus Estimate in each of its trailing four quarters, with the average earnings surprise being 8.3%.
Docusign also holds a Zacks Rank of 2 at present. It has a long-term earnings growth expectation of 14.9%.
DOCU delivered a trailing four-quarter average earnings surprise of 9.2%.
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Paychex (PAYX - Free Report) , which belongs to the Zacks Internet - Software industry.
This payroll processor and human-resources services provider has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 1.70%.
For the last reported quarter, Paychex came out with earnings of $1.71 per share versus the Zacks Consensus Estimate of $1.68 per share, representing a surprise of 1.79%. For the previous quarter, the company was expected to post earnings of $1.24 per share and it actually produced earnings of $1.26 per share, delivering a surprise of 1.61%.
Price and EPS Surprise
With this earnings history in mind, recent estimates have been moving higher for Paychex. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Paychex currently has an Earnings ESP of +0.22%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner.
With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.
Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
ROCHESTER, N.Y., June 02, 2026 (GLOBE NEWSWIRE) -- The Paychex Small Business Jobs Index – a primary component of the Paychex Small Business Employment Watch that measures the pace of job growth among U.S. small businesses with fewer than 50 employees – improved for the third consecutive month in May, a first since February 2023. The jobs index increased 0.18 percentage points in May to 99.34, marking its highest level so far in 2026. While hourly earnings growth remained steady at 2.73% in May, U.S. small business workers experienced continued growth in both weekly hours worked and earnings for the month.
“The small business job growth rate has increased three consecutive months, reinforcing the durability and underlying strength of the labor market on Main Street,” said John Gibson, Paychex president and CEO. “Most states and metros analyzed in our jobs index reported an increase in May, reflecting consistency across geographies as we head into the summer. We see a similar trends across our client base, as businesses with more than 50 employees continue to add workers at a solid pace.”
Jobs Index and Wage Data Highlights
Weekly earnings growth (2.98%) increased for the fifth consecutive month in May to its highest level since January 2024 (3.08%).Weekly hours worked growth (0.12%) was positive for the third consecutive month in May. This is the first three-month positive streak since April 2021, when weekly hours worked increased for four consecutive months.Of the top 20 largest states analyzed, 14 recorded an increase in small business job growth in May. Tennessee gained 1.62 percentage points to a jobs index of 100.87, including a more than five-percentage-point gain in the Manufacturing and Construction sectors for the month.Small business job growth increased in 15 of the top 20 largest U.S. metros in May, including Phoenix (100.95) reclaiming its position as the top-ranked metro for the fifth time in the last eight months.Education and Health Services (100.37) continued to lead sectors for small business job growth in May, the position it has held in all but one month since 2024.Manufacturing (99.04) reported the strongest one-, three-, and 12-month increases in small business job growth among industries. About the Paychex Small Business Employment Watch
Since 2014, the Paychex Small Business Employment Watch has been a trusted source of employment trends for U.S. small businesses with fewer than 50 employees. The Employment Watch website offers interactive charts and historical data across the report’s two key components – the jobs index and wage data – as well as the methodology for both analyses. Visit the Bloomberg Terminals or subscribe to receive monthly alerts with the latest data.
*Information regarding the professions included in the industry data can be found at the Bureau of Labor Statistics website.
About Paychex
Paychex, Inc. (Nasdaq: PAYX) is the digitally driven HR leader that is reimagining how companies address the needs of today’s workforce with the most comprehensive, flexible, and innovative HCM solutions for organizations of all sizes. Offering a full spectrum of HR advisory and employee solutions, Paychex pays 1 out of every 11 American private sector workers and is raising the bar in HCM for approximately 800,000 customers in the U.S. and Europe. Every member of the Paychex team is committed to fulfilling the company’s purpose of helping businesses succeed. Visit paychex.com to learn more.
Media Contacts
Tracy Volkmann
Paychex, Inc.
Manager, Public Relations
(585) 387-6705 [email protected]
@Paychex
ROCHESTER, N.Y., June 10, 2026 (GLOBE NEWSWIRE) -- Paychex, Inc. (Nasdaq: PAYX), an industry-leading human capital management ("HCM") company, will release financial results for its fiscal 2026 fourth quarter and full-year ended May 31, 2026 on Wednesday, June 24, 2026, before the financial markets open.
The company will host a conference call at 9:30 a.m. ET on Wednesday, June 24, 2026 to discuss these results. Participating in this call will be John Gibson, President and Chief Executive Officer, and Bob Schrader, Chief Financial Officer.
The conference call will be webcast live and available for replay on the Paychex Investor Relations portal.
About Paychex
Paychex, Inc. (Nasdaq: PAYX) is the digitally driven HR leader that is reimagining how companies address the needs of today’s workforce with the most comprehensive, flexible, and innovative HCM solutions for organizations of all sizes. Offering a full spectrum of HR advisory and employee solutions, Paychex pays 1 out of every 11 American private sector workers and is raising the bar in HCM for approximately 800,000 customers in the U.S. and Europe. Every member of the Paychex team is committed to fulfilling the company’s purpose of helping businesses succeed. Visit paychex.com to learn more. Visit paychex.com to learn more.
Paychex, Inc.’s news releases, current financial information, SEC filings, and investor presentations are accessible on the Paychex Investor Relations portal.
Contacts
Investor Relations:
Rachel White
Head of Investor Relations
(585) 216-0822 [email protected]
Media Relations:
Tracy Volkmann
Manager, Public Relations
(585) 387-6705 [email protected]
HOUSTON--(BUSINESS WIRE)--Corebridge Financial, Inc. (NYSE: CRBG) today announced that it will report first quarter 2026 financial results after the market closes on Monday, May 4, 2026. Corebridge earnings materials will be available in the Investors section of corebridgefinancial.com.
Corebridge will host a conference call at 10:00 a.m. EDT on Tuesday, May 5, 2026, to review these results. The webcast can be accessed in the Investors section of corebridgefinancial.com, and a replay will be available shortly after the event.
About Corebridge Financial
Corebridge Financial, Inc. makes it possible for more people to take action in their financial lives. With more than $385 billion in assets under management and administration as of December 31, 2025, Corebridge Financial is one of the largest providers of retirement solutions and insurance products in the United States. We proudly partner with financial professionals and institutions to help individuals plan, save for and achieve secure financial futures. For more information, visit corebridgefinancial.com and follow us on LinkedIn.
Massachusetts Financial Services Co. MA cut its stake in shares of Corebridge Financial, Inc. (NYSE:CRBG – Free Report) by 9.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,349,746 shares of the company’s stock after selling 811,172 shares during the period. Massachusetts Financial Services Co. MA owned approximately 1.41% of Corebridge Financial worth $221,742,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the stock. Bank of Nova Scotia increased its position in shares of Corebridge Financial by 3.8% during the second quarter. Bank of Nova Scotia now owns 9,328 shares of the company’s stock valued at $331,000 after acquiring an additional 340 shares during the last quarter. Severin Investments LLC increased its position in shares of Corebridge Financial by 1.4% during the third quarter. Severin Investments LLC now owns 24,778 shares of the company’s stock valued at $794,000 after acquiring an additional 350 shares during the last quarter. Smartleaf Asset Management LLC increased its position in shares of Corebridge Financial by 83.6% during the third quarter. Smartleaf Asset Management LLC now owns 828 shares of the company’s stock valued at $27,000 after acquiring an additional 377 shares during the last quarter. Integrated Wealth Concepts LLC increased its position in shares of Corebridge Financial by 2.5% during the third quarter. Integrated Wealth Concepts LLC now owns 15,424 shares of the company’s stock valued at $494,000 after acquiring an additional 383 shares during the last quarter. Finally, True Wealth Design LLC increased its position in shares of Corebridge Financial by 50.2% during the fourth quarter. True Wealth Design LLC now owns 1,233 shares of the company’s stock valued at $37,000 after acquiring an additional 412 shares during the last quarter. 98.25% of the stock is currently owned by institutional investors and hedge funds.
Corebridge Financial Price Performance Shares of CRBG opened at $24.43 on Monday. Corebridge Financial, Inc. has a fifty-two week low of $22.19 and a fifty-two week high of $36.57. The firm’s 50 day moving average price is $26.48 and its 200 day moving average price is $29.25. The company has a market cap of $11.77 billion, a P/E ratio of -46.08, a PEG ratio of 0.39 and a beta of 1.12. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 0.11.
Corebridge Financial (NYSE:CRBG – Get Free Report) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.11 by $0.11. Corebridge Financial had a negative net margin of 1.73% and a positive return on equity of 18.92%. The company had revenue of $6.34 billion during the quarter, compared to analysts’ expectations of $5.02 billion. During the same quarter in the previous year, the business posted $1.06 EPS. On average, research analysts forecast that Corebridge Financial, Inc. will post 5.43 earnings per share for the current fiscal year.
Corebridge Financial Increases Dividend The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th were given a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 4.1%. This is a boost from Corebridge Financial’s previous quarterly dividend of $0.24. Corebridge Financial’s payout ratio is currently -188.68%.
Wall Street Analyst Weigh In A number of brokerages have weighed in on CRBG. UBS Group dropped their price target on shares of Corebridge Financial from $35.00 to $33.00 and set a “neutral” rating for the company in a research report on Thursday, January 8th. Keefe, Bruyette & Woods cut their target price on shares of Corebridge Financial from $32.00 to $31.00 and set an “outperform” rating on the stock in a research note on Friday. Zacks Research raised shares of Corebridge Financial from a “strong sell” rating to a “hold” rating in a research note on Friday, March 6th. Piper Sandler raised shares of Corebridge Financial to a “strong-buy” rating in a research note on Thursday, April 2nd. Finally, Wells Fargo & Company cut their target price on shares of Corebridge Financial from $36.00 to $32.00 and set an “overweight” rating on the stock in a research note on Friday. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $35.55.
View Our Latest Analysis on Corebridge Financial
Corebridge Financial Profile (Free Report)
Corebridge Financial (NYSE: CRBG) is a publicly traded provider of retirement, life insurance and asset management solutions. Formed from the separation of American International Group’s life and retirement operations, Corebridge focuses on helping individuals, employers and institutions manage retirement income, protect against longevity and mortality risks, and invest long-term savings. The company operates under a unified brand that brings together insurance products and investment capabilities to deliver integrated financial solutions.
Corebridge’s product suite includes retirement income and annuity products, individual and group life insurance, asset management and investment advisory services, and employer-sponsored retirement plan offerings.
Featured Stories Five stocks we like better than Corebridge Financial Want to see what other hedge funds are holding CRBG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corebridge Financial, Inc. (NYSE:CRBG – Free Report).
Receive News & Ratings for Corebridge Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corebridge Financial and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINERidgecrest Wealth Partners LLC Sells 7,343 Shares of Exxon Mobil Corporation $XOM
NEXT HEADLINE »Massachusetts Financial Services Co. MA Has $227.87 Million Position in Intel Corporation $INTC
HOUSTON--(BUSINESS WIRE)--Corebridge Financial, Inc. (“Corebridge” or the “Company”) (NYSE: CRBG) today announced the appointment of the Company’s Chief Accounting Officer Christopher Filiaggi as Interim Chief Financial Officer, effective April 24, 2026. Filiaggi will report to Marc Costantini, President and Chief Executive Officer, and join the Executive Leadership Team.
Filiaggi will serve as Interim Chief Financial Officer while the Company prepares for its planned merger (the “Proposed Transaction”) with Equitable Holdings, Inc. (“Equitable Holdings”). In this role, he will provide continuity, disciplined execution and steady financial leadership as Corebridge advances toward the combination.
“Chris is a deeply respected leader within our world-class finance team, with the experience and judgment to guide the organization through this transition,” said Costantini. “This internal appointment reflects the depth of talent and financial acumen we have at Corebridge.”
Filiaggi has served as Chief Accounting Officer for Corebridge since June 2023, overseeing financial reporting, accounting policy and internal controls. Prior to this role, he held finance leadership positions with Corebridge and American International Group, Inc. (AIG). Previously, Filiaggi was with PricewaterhouseCoopers LLP, advising insurance clients on accounting policies and regulatory compliance.
This appointment follows the previously announced transition of the Company’s current Chief Financial Officer, Elias Habayeb, who will continue with Corebridge through April 24, 2026. Filiaggi will remain in the interim role until the closing of the Proposed Transaction, when Robin M. Raju, Chief Financial Officer of Equitable Holdings, will serve as Chief Financial Officer of the combined company.
About Corebridge Financial
Corebridge Financial, Inc. makes it possible for more people to take action in their financial lives. With more than $385 billion in assets under management and administration as of December 31, 2025, Corebridge Financial is one of the largest providers of retirement solutions and insurance products in the United States. We proudly partner with financial professionals and institutions to help individuals plan, save for and achieve secure financial futures. For more information, visit corebridgefinancial.com and follow us on LinkedIn.
Cautionary Statement Regarding Forward-Looking Information
This press release includes statements, which, to the extent they are not statements of historical or present fact, constitute “forward looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements, and any related oral statements, can be identified by the use of terms such as “believes,” “expects,” “may,” “will,” “shall,” “should,” “would,” “could,” “seeks,” “aims,” “projects,” “forecasts,” “intends,” “targets,” “plans,” “estimates,” “anticipates,” “goals,” “guidance,” “formidable,” “preliminary,” “objective,” “continue,” “drive,” “improve,” “superior,” “robust,” “positioned,” “resilient,” “vision,” “potential,” “immediate,” and similar expressions or the negative of those expressions or verbs. We caution you that forward-looking statements are not guarantees of future performance or outcomes. Forward-looking statements are not historical facts but instead represent only our beliefs regarding future events, which may by their nature be inherently uncertain, and some of which may be outside our control. These statements include, but are not limited to, statements about the expected timing and completion of the Proposed Transaction, the anticipated benefits of the Proposed Transaction, including estimated synergies and projected cost savings, and plans and expectations for Corebridge, Equitable Holdings or their new parent company after completion of the Proposed Transaction.
Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Key factors include, among others, the ability to complete the Proposed Transaction on the timeframe or on the terms currently anticipated or at all, including due to a failure to obtain requisite stockholder, stock exchange, regulatory, governmental or other approvals; risks related to difficulties, inabilities or delays in integrating the parties’ businesses; the ability to realize the anticipated benefits of the Proposed Transaction, including estimated run-rate expense synergies and projected cost savings at the times, and to the extent, anticipated, as well as expected operating earning and cashflow generation; the occurrence of any event, change or other circumstance that could give rise to the right of either or both parties to terminate the merger agreement; the potential impact of the announcement or consummation of the Proposed Transaction on Corebridge or Equitable Holdings’ stock price and on their respective business, contractual and operational relationships (including with regulatory bodies, employees, suppliers, clients and competitors); risks related to business disruptions from the Proposed Transaction that may harm the business or current plans and operations of either or both parties, including diversion of management time from ongoing business operations; the risk that the Proposed Transaction and its announcement could have an adverse effect on the ability of either or both parties to hire and retain key personnel; the parties’ ability to raise debt on favorable terms or at all; the outcome of any legal proceedings that may be instituted against Corebridge, Equitable Holdings, their new parent company or their respective directors; restrictions on the conduct of Corebridge and Equitable Holdings’ respective businesses prior to the closing of the Proposed Transaction and on each their ability to pursue alternatives to the Proposed Transaction; the possibility that the Proposed Transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events, or unforeseen or unknown liabilities; the deterioration of economic conditions; geopolitical tensions; the potential impact of a downgrade in Corebridge or Equitable Holdings’ Insurer Financial Strength ratings or credit ratings or of the new parent company of Corebridge and Equitable Holdings following completion of the Proposed Transaction; other factors that may affect future results of Corebridge and Equitable Holdings; and management’s response to any of the aforementioned factors.
The foregoing list of factors is not exhaustive. You should carefully consider these factors and the other risks and uncertainties described in the “Risk Factors” section of the new parent company’s Registration Statement on Form S-4 discussed below and other documents filed or furnished by Corebridge and Equitable Holdings from time to time with the U.S. Securities and Exchange Commission (the “SEC”), including their Annual Reports on Form 10-K for the year ended December 31, 2025. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. If any of these risks materialize or our assumptions prove incorrect, actual events and results could differ materially from those contained in the forward-looking statements. There may be additional risks that neither Corebridge nor Equitable Holdings presently know or that Corebridge and Equitable Holdings currently believe are immaterial that could also cause actual events and results to differ materially from those contained in the forward-looking statements. In addition, forward-looking statements reflect Corebridge and Equitable Holdings’ expectations, plans or forecasts of future events and views as of the date of this press release. Corebridge and Equitable Holdings anticipate that subsequent events and developments will cause Corebridge and Equitable Holdings’ assessments to change. While Corebridge and Equitable Holdings may elect to update these forward-looking statements at some point in the future, Corebridge and Equitable Holdings specifically disclaim any obligation to do so, unless required by applicable law. Neither Corebridge nor Equitable Holdings gives any assurance that Corebridge, Equitable Holdings or their new parent company will achieve the results or other matters set forth in the forward-looking statements.
No Offer or Solicitation
This press release is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the “Securities Act”), or in a transaction exempt from the registration requirements of the Securities Act.
Important Information and Where to Find It
This press release relates to the Proposed Transaction that may become the subject of a Registration Statement on Form S-4 to be filed by the new parent company with the SEC. The Registration Statement will include a joint proxy statement of Corebridge and Equitable Holdings that will also constitute a prospectus of the new parent company. After the Registration Statement has been declared effective, the definitive joint proxy statement/prospectus will be mailed to the stockholders of each of Corebridge and Equitable Holdings. This press release is not a substitute for the Registration Statement that the new parent company intends to file with the SEC or any other documents that may be sent to Corebridge’s stockholders or Equitable Holdings’ stockholders in connection with the Proposed Transaction.
INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT ON FORM S-4 AND THE JOINT PROXY STATEMENT/PROSPECTUS WHEN THEY BECOME AVAILABLE, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH, OR FURNISHED TO, THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE INTO THE JOINT PROXY STATEMENT/PROSPECTUS, BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION REGARDING COREBRIDGE, EQUITABLE HOLDINGS, THEIR NEW PARENT COMPANY, THE PROPOSED TRANSACTION AND RELATED MATTERS.
Investors and security holders may obtain free copies of these documents and other documents filed with the SEC by Corebridge or Equitable Holdings through the website maintained by the SEC at http://www.sec.gov or from Corebridge at its website, https://www.corebridgefinancial.com, or from Equitable Holdings at its website, https://equitableholdings.com (information included on or accessible through either of Corebridge or Equitable Holdings’ website is not incorporated by reference into this press release).
Participants in the Solicitation
Corebridge and Equitable Holdings and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from Corebridge’s stockholders or Equitable Holdings’ stockholders in connection with the Proposed Transaction under the rules of the SEC. Information about the directors and executive officers of Corebridge, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in Corebridge’s definitive proxy statement for its 2025 Annual Meeting of Stockholders, which was filed with the SEC on April 16, 2025, including under the headings “Compensation Discussion and Analysis,” “Compensation Tables” and “Security Ownership of 5% Beneficial Owners, Directors and Executive Officers.” To the extent holdings of Corebridge’s common stock by the directors and executive officers of Corebridge have changed or do change from the amounts of Corebridge’s common stock held by such persons as reflected therein, such changes have been or will be reflected on Initial Statements of Beneficial Ownership of Securities on Form 3 (“Form 3”), Statements of Changes in Beneficial Ownership on Form 4 (“Form 4”) or Annual Statements of Changes in Beneficial Ownership of Securities on Form 5 (“Form 5”), in each case filed with the SEC. Information about the directors and executive officers of Equitable Holdings, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in Equitable Holdings’ definitive proxy statement for its 2025 Annual Meeting of Stockholders, which was filed with the SEC on April 4, 2025, including under the headings “Executive Compensation” and “Certain Relationships and Related Person Transactions.” To the extent holdings of Equitable Holdings’ common stock by the directors and executive officers of Equitable Holdings have changed or do change from the amounts of Equitable Holdings’ common stock held by such persons as reflected therein, such changes have been or will be reflected on Forms 3, Forms 4 or Forms 5, in each case filed with the SEC. Other information regarding persons who may, under the rules of the SEC, be deemed participants in the proxy solicitation of Corebridge or Equitable Holdings’ stockholders in connection with the Proposed Transaction and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Registration Statement. You may obtain free copies of these documents at the SEC’s website at www.sec.gov. Copies of documents filed with the SEC by Corebridge or Equitable Holdings will also be available free of charge from Corebridge or Equitable Holdings using the contact information above.
HOUSTON--(BUSINESS WIRE)--Corebridge Financial, Inc. (NYSE: CRBG) today announced that its Board of Directors elected Hirotaka Inoue as a director effective April 21, 2026. Mr. Inoue will serve as a Nippon Life Insurance Company-designated director and will replace Minoru Kimura, who will depart from the Board effective April 20, 2026. “We are pleased to welcome Hirotaka Inoue to the Corebridge Board,” said Alan Colberg, Chair of the Board of Corebridge Financial. “Hiro brings deep expertise in.
State of Alaska Department of Revenue bought a new stake in shares of Corebridge Financial, Inc. (NYSE:CRBG – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 26,555 shares of the company’s stock, valued at approximately $801,000.
A number of other large investors have also recently modified their holdings of the stock. Vanguard Group Inc. raised its position in shares of Corebridge Financial by 7.2% in the 3rd quarter. Vanguard Group Inc. now owns 26,831,915 shares of the company’s stock worth $859,963,000 after acquiring an additional 1,805,819 shares in the last quarter. Pzena Investment Management LLC raised its position in shares of Corebridge Financial by 19.3% in the 3rd quarter. Pzena Investment Management LLC now owns 22,329,199 shares of the company’s stock worth $715,651,000 after acquiring an additional 3,605,498 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Corebridge Financial by 6.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,686,747 shares of the company’s stock worth $214,372,000 after acquiring an additional 430,308 shares in the last quarter. LSV Asset Management raised its position in shares of Corebridge Financial by 2.1% in the 3rd quarter. LSV Asset Management now owns 4,685,535 shares of the company’s stock worth $150,171,000 after acquiring an additional 98,435 shares in the last quarter. Finally, Bank of America Corp DE raised its position in shares of Corebridge Financial by 42.8% in the 2nd quarter. Bank of America Corp DE now owns 2,884,599 shares of the company’s stock worth $102,403,000 after acquiring an additional 864,946 shares in the last quarter. Institutional investors own 98.25% of the company’s stock.
Wall Street Analysts Forecast Growth Several research analysts have recently issued reports on the company. Piper Sandler raised Corebridge Financial to a “strong-buy” rating in a research report on Thursday, April 2nd. Barclays dropped their target price on shares of Corebridge Financial from $33.00 to $30.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. Weiss Ratings cut shares of Corebridge Financial from a “buy (b-)” rating to a “hold (c+)” rating in a report on Thursday, January 15th. Bank of America dropped their target price on shares of Corebridge Financial from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Corebridge Financial from $40.00 to $39.00 and set a “neutral” rating on the stock in a report on Monday, January 5th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $35.33.
View Our Latest Stock Analysis on Corebridge Financial
Corebridge Financial Trading Up 1.2% Corebridge Financial stock opened at $26.60 on Thursday. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 0.11. The business’s fifty day simple moving average is $25.75 and its two-hundred day simple moving average is $28.92. Corebridge Financial, Inc. has a 12 month low of $22.19 and a 12 month high of $36.57. The company has a market capitalization of $12.81 billion, a price-to-earnings ratio of -50.18, a price-to-earnings-growth ratio of 0.43 and a beta of 1.12.
Corebridge Financial (NYSE:CRBG – Get Free Report) last released its earnings results on Wednesday, February 11th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.11 by $0.11. Corebridge Financial had a positive return on equity of 18.92% and a negative net margin of 1.73%.The business had revenue of $6.34 billion for the quarter, compared to the consensus estimate of $5.02 billion. During the same period in the previous year, the company posted $1.06 earnings per share. As a group, equities analysts predict that Corebridge Financial, Inc. will post 5.04 earnings per share for the current fiscal year.
Corebridge Financial Increases Dividend The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th were paid a dividend of $0.25 per share. The ex-dividend date was Tuesday, March 17th. This represents a $1.00 dividend on an annualized basis and a yield of 3.8%. This is an increase from Corebridge Financial’s previous quarterly dividend of $0.24. Corebridge Financial’s dividend payout ratio (DPR) is -188.68%.
About Corebridge Financial (Free Report)
Corebridge Financial (NYSE: CRBG) is a publicly traded provider of retirement, life insurance and asset management solutions. Formed from the separation of American International Group’s life and retirement operations, Corebridge focuses on helping individuals, employers and institutions manage retirement income, protect against longevity and mortality risks, and invest long-term savings. The company operates under a unified brand that brings together insurance products and investment capabilities to deliver integrated financial solutions.
Corebridge’s product suite includes retirement income and annuity products, individual and group life insurance, asset management and investment advisory services, and employer-sponsored retirement plan offerings.
Recommended Stories Five stocks we like better than Corebridge Financial
Receive News & Ratings for Corebridge Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corebridge Financial and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINERoyal Bank Of Canada Issues Positive Forecast for BOK Financial (NASDAQ:BOKF) Stock Price
NEXT HEADLINE »State of Alaska Department of Revenue Raises Stock Position in Gulfport Energy Corporation $GPOR
Cwm LLC boosted its position in Corebridge Financial, Inc. (NYSE:CRBG – Free Report) by 50.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 95,059 shares of the company’s stock after purchasing an additional 31,892 shares during the period. Cwm LLC’s holdings in Corebridge Financial were worth $2,868,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently added to or reduced their stakes in the company. Community Bank N.A. acquired a new position in Corebridge Financial during the 3rd quarter worth approximately $26,000. Smartleaf Asset Management LLC boosted its stake in shares of Corebridge Financial by 83.6% in the third quarter. Smartleaf Asset Management LLC now owns 828 shares of the company’s stock valued at $27,000 after buying an additional 377 shares in the last quarter. Root Financial Partners LLC purchased a new stake in shares of Corebridge Financial in the third quarter valued at approximately $32,000. True Wealth Design LLC grew its holdings in Corebridge Financial by 50.2% during the fourth quarter. True Wealth Design LLC now owns 1,233 shares of the company’s stock worth $37,000 after acquiring an additional 412 shares during the period. Finally, Assetmark Inc. grew its holdings in Corebridge Financial by 47.7% during the third quarter. Assetmark Inc. now owns 1,390 shares of the company’s stock worth $45,000 after acquiring an additional 449 shares during the period. Hedge funds and other institutional investors own 98.25% of the company’s stock.
Wall Street Analyst Weigh In CRBG has been the subject of a number of recent analyst reports. Barclays reduced their target price on Corebridge Financial from $33.00 to $30.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. Weiss Ratings cut shares of Corebridge Financial from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, January 15th. Zacks Research raised shares of Corebridge Financial from a “strong sell” rating to a “hold” rating in a research note on Friday, March 6th. UBS Group lowered their price target on shares of Corebridge Financial from $35.00 to $33.00 and set a “neutral” rating on the stock in a research note on Thursday, January 8th. Finally, TD Cowen lowered their price target on shares of Corebridge Financial from $38.00 to $35.00 and set a “buy” rating on the stock in a research note on Tuesday, March 10th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, Corebridge Financial currently has an average rating of “Moderate Buy” and a consensus target price of $35.33.
Check Out Our Latest Report on CRBG
Corebridge Financial Stock Performance NYSE:CRBG opened at $26.53 on Friday. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 0.11. Corebridge Financial, Inc. has a fifty-two week low of $22.19 and a fifty-two week high of $36.57. The stock has a market cap of $12.78 billion, a PE ratio of -50.06, a price-to-earnings-growth ratio of 0.36 and a beta of 1.12. The firm’s fifty day simple moving average is $25.67 and its 200-day simple moving average is $28.90.
Corebridge Financial (NYSE:CRBG – Get Free Report) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.11. Corebridge Financial had a negative net margin of 1.73% and a positive return on equity of 18.92%. The business had revenue of $6.34 billion for the quarter, compared to analysts’ expectations of $5.02 billion. During the same period in the prior year, the company posted $1.06 EPS. Analysts expect that Corebridge Financial, Inc. will post 4.99 earnings per share for the current fiscal year.
Corebridge Financial Increases Dividend The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date of this dividend was Tuesday, March 17th. This is a positive change from Corebridge Financial’s previous quarterly dividend of $0.24. Corebridge Financial’s dividend payout ratio is currently -188.68%.
About Corebridge Financial (Free Report)
Corebridge Financial (NYSE: CRBG) is a publicly traded provider of retirement, life insurance and asset management solutions. Formed from the separation of American International Group’s life and retirement operations, Corebridge focuses on helping individuals, employers and institutions manage retirement income, protect against longevity and mortality risks, and invest long-term savings. The company operates under a unified brand that brings together insurance products and investment capabilities to deliver integrated financial solutions.
Corebridge’s product suite includes retirement income and annuity products, individual and group life insurance, asset management and investment advisory services, and employer-sponsored retirement plan offerings.
Read More Five stocks we like better than Corebridge Financial Want to see what other hedge funds are holding CRBG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corebridge Financial, Inc. (NYSE:CRBG – Free Report).
Receive News & Ratings for Corebridge Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corebridge Financial and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECwm LLC Buys 24,139 Shares of Essent Group Ltd. $ESNT
NEXT HEADLINE »B. Metzler seel. Sohn & Co. AG Has $8.97 Million Stock Holdings in GE Vernova Inc. $GEV
The market expects Corebridge Financial (CRBG - Free Report) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on May 4, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis financial services company is expected to post quarterly earnings of $1.09 per share in its upcoming report, which represents a year-over-year change of -6%.
Revenues are expected to be $4.76 billion, up 0.5% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 2.99% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Corebridge?For Corebridge, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.05%.
On the other hand, the stock currently carries a Zacks Rank of #4.
So, this combination makes it difficult to conclusively predict that Corebridge will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Corebridge would post earnings of $1.11 per share when it actually produced earnings of $1.22, delivering a surprise of +9.91%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Corebridge doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsAnother stock from the Zacks Insurance - Multi line industry, Hippo Holdings Inc. (HIPO - Free Report) , is soon expected to post earnings of $0.29 per share for the quarter ended March 2026. This estimate indicates a year-over-year change of +115.2%. Revenues for the quarter are expected to be $129.8 million, up 17.7% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Hippo Holdings has been revised 237.5% up to the current level. Nevertheless, the company now has an Earnings ESP of +27.59%, reflecting a higher Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), suggests that Hippo Holdings will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Wall Street expects a year-over-year decline in earnings on higher revenues when Prudential (PRU - Free Report) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 5. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis financial services company is expected to post quarterly earnings of $3.23 per share in its upcoming report, which represents a year-over-year change of -1.8%.
Revenues are expected to be $14.31 billion, up 6.7% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 3.24% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Prudential?For Prudential, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -3.41%.
On the other hand, the stock currently carries a Zacks Rank of #4.
So, this combination makes it difficult to conclusively predict that Prudential will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Prudential would post earnings of $3.37 per share when it actually produced earnings of $3.30, delivering a surprise of -2.08%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Prudential doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsAnother stock from the Zacks Insurance - Multi line industry, Corebridge Financial (CRBG - Free Report) , is soon expected to post earnings of $1.09 per share for the quarter ended March 2026. This estimate indicates a year-over-year change of -6%. Revenues for the quarter are expected to be $4.76 billion, up 0.5% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Corebridge has been revised 3% down to the current level. Nevertheless, the company now has an Earnings ESP of -3.82%, reflecting a lower Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #4 (Sell), makes it difficult to conclusively predict that Corebridge will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
HOUSTON--(BUSINESS WIRE)--Corebridge Financial, Inc. ("Corebridge" or the "Company") (NYSE: CRBG) today reported financial results for the first quarter ended March 31, 2026. “Corebridge delivered strong financial results in the first quarter,” said Marc Costantini, President and Chief Executive Officer. “Earnings per share and return on equity both improved year over year. This, alongside consistent organic growth and the proceeds from our variable annuity transaction, supported a record retur.
Corebridge Financial (CRBG - Free Report) came out with quarterly earnings of $1.05 per share, missing the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.16 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -1.43%. A quarter ago, it was expected that this financial services company would post earnings of $1.11 per share when it actually produced earnings of $1.22, delivering a surprise of +9.91%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Corebridge, which belongs to the Zacks Insurance - Multi line industry, posted revenues of $4.09 billion for the quarter ended March 2026, missing the Zacks Consensus Estimate by 14.18%. This compares to year-ago revenues of $4.74 billion. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Corebridge shares have lost about 8.8% since the beginning of the year versus the S&P 500's gain of 5.6%.
What's Next for Corebridge?While Corebridge has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Corebridge was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.22 on $4.75 billion in revenues for the coming quarter and $4.91 on $20.69 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Insurance - Multi line is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Octave Specialty Group (OSG - Free Report) , has yet to report results for the quarter ended March 2026. The results are expected to be released on May 6.
This bond insurer is expected to post quarterly earnings of $0.04 per share in its upcoming report, which represents a year-over-year change of +130.8%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Octave Specialty Group's revenues are expected to be $83.46 million, up 33% from the year-ago quarter.
Corebridge Financial (CRBG - Free Report) reported $4.09 billion in revenue for the quarter ended March 2026, representing a year-over-year decline of 13.8%. EPS of $1.05 for the same period compares to $1.16 a year ago.
The reported revenue represents a surprise of -14.18% over the Zacks Consensus Estimate of $4.76 billion. With the consensus EPS estimate being $1.07, the EPS surprise was -1.43%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Corebridge performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Premiums: $387 million versus $1.12 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -56.5% change.Total Corebridge- Advisory fee and other income: $106 million versus the four-analyst average estimate of $102.51 million. The reported number represents a year-over-year change of -48.5%.Policy fees: $594 million versus $616.86 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -17.5% change.Total Corebridge- Net investment income: $2.99 billion versus $3.03 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +2.8% change.Revenue- Life Insurance: $1.04 billion versus the three-analyst average estimate of $1.06 billion. The reported number represents a year-over-year change of +0.1%.Revenue- Individual Retirement: $1.63 billion versus the three-analyst average estimate of $1.68 billion. The reported number represents a year-over-year change of -10.6%.Revenue- Corporate & Other: $14 million versus the three-analyst average estimate of $30.73 million. The reported number represents a year-over-year change of -74.1%.Revenue- Individual Retirement- Premiums: $16 million compared to the $26.38 million average estimate based on three analysts. The reported number represents a change of -40.7% year over year.Revenue- Individual Retirement- Policy fees: $77 million versus the three-analyst average estimate of $85.15 million. The reported number represents a year-over-year change of -61.1%.Revenue- Individual Retirement- Net investment income: $1.54 billion versus the three-analyst average estimate of $1.56 billion. The reported number represents a year-over-year change of +3.3%.Revenue- Group Retirement- Premiums: $1 million versus the three-analyst average estimate of $3.92 million. The reported number represents a year-over-year change of -75%.Revenue- Group Retirement- Policy fees: $109 million versus $112.03 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +0.9% change.View all Key Company Metrics for Corebridge here>>>
Shares of Corebridge have returned +14.6% over the past month versus the Zacks S&P 500 composite's +10% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
HOUSTON--(BUSINESS WIRE)--Corebridge Financial, Inc. (NYSE: CRBG) today announced that it has declared a dividend of $36.85763889 per share on its 6.875% fixed rate reset non-cumulative preferred stock, Series A, with a liquidation preference of $1,000 per share. The declared dividend includes the regular semi-annual dividend and a stub dividend for the period from the Series A preferred stock's issuance on November 13, 2025, through November 30, 2025. The dividend is payable on June 1, 2026, t.
NEW YORK--(BUSINESS WIRE)--American International Group, Inc. (NYSE: AIG) today announced that it has agreed to sell approximately 25 million shares of common stock of Corebridge Financial, Inc. (NYSE: CRBG), representing its remaining stake in the company. The sale, which is expected to close on May 7, will result in net proceeds to AIG of approximately $710 million.
Peter Zaffino, Chairman & CEO, AIG, said, “Today’s sale of our remaining stake in Corebridge marks the culmination of a five-year separation and a significant milestone in the successful execution of our strategy to exit the life and retirement business. We have transformed AIG into a more focused, leading, global property & casualty insurance company. This final step reflects years of disciplined planning, commitment, execution, and perseverance. Since Corebridge’s IPO in 2022, we have worked to ensure the company had the capabilities to operate effectively as a stand-alone organization and is well positioned for long-term success. I would like to thank our colleagues at both AIG and Corebridge for their outstanding work executing the separation and positioning both companies for continued momentum.”
About AIG
American International Group, Inc. (NYSE: AIG) is a leading global insurance organization. AIG provides insurance solutions that help businesses and individuals in more than 200 countries and jurisdictions protect their assets and manage risks through AIG operations, licenses and authorizations as well as network partners. For additional information, visit www.aig.com. This website with additional information about AIG has been provided as a convenience, and the information contained on such website is not incorporated by reference into this press release.
AIG is the marketing name for the worldwide operations of American International Group, Inc. All products and services are written or provided by subsidiaries or affiliates of American International Group, Inc. Products or services may not be available in all countries and jurisdictions, and coverage is subject to underwriting requirements and actual policy language. Non-insurance products and services may be provided by independent third parties. Certain property casualty coverages may be provided by a surplus lines insurer. Surplus lines insurers do not generally participate in state guaranty funds, and insureds are therefore not protected by such funds.
HOUSTON--(BUSINESS WIRE)--Corebridge Financial, Inc. (NYSE: CRBG) today announced that Marc Costantini, President and Chief Executive Officer, and Christopher Filiaggi, Interim Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley U.S. Financials Conference at 3:15 p.m. EDT on Tuesday, June 9, 2026. The live webcast can be accessed in the Investors section of corebridgefinancial.com, and a replay will be available after the event. About Corebridge Financial Corebrid.
HOUSTON--(BUSINESS WIRE)--Baltimore City Public Schools (City Schools) has selected Corebridge Financial as the sole provider for its supplemental retirement savings plans. By consolidating from 12 providers to Corebridge exclusively, City Schools is able to reduce fees for its PK-12 workforce, enabling participants to keep more of their investment returns and help improve their long-term financial outcomes.
“Our plan consolidation with Corebridge represents an important evolution of our retirement benefits program, providing our educators and staff with greater financial clarity, retirement security, and confidence in their future,” said Christopher J. Doherty, Chief Financial Officer, Baltimore City Public Schools.
Corebridge, which has worked with City Schools for four decades as one of multiple providers, will now serve as the sole provider of the school system’s 403(b) and 457(b) retirement plans, covering approximately 10,000 participants and overseeing roughly $500 million in plan assets. Following an extensive competitive review, Corebridge emerged as the provider of choice, offering participants:
Lower fees No surrender fees Expanded investment options Personalized support from financial professionals Simplified experiences, communications and account management “Our longstanding relationship with Baltimore City Public Schools has given us a deep understanding of the needs of their educators and staff, and we take that responsibility seriously,” said Terri Fiedler, President of Retirement Services at Corebridge. “By transitioning to a more streamlined, participant-focused model, City Schools is positioning its retirement program for the future, and we’re proud to support that vision with our extensive experience serving K–12 school systems and proven ability to manage large-scale consolidations.”
Corebridge has served the retirement needs of K-12 educators and staff for more than 60 years, dating back to 1964 when Corebridge implemented one of the first-ever 403(b) retirement plans in a public school. Today, Corebridge remains an industry leader in the public K-12 marketplace as a top 3 retirement plan provider by assets, continuing to innovate and help school districts across the country modernize their defined contribution plans.1
Corebridge Financial, Inc. (NYSE: CRBG) makes it possible for more people to take action in their financial lives. With more than $380 billion in assets under management and administration as of March 31, 2026, Corebridge Financial is one of the largest providers of retirement solutions and insurance products in the United States. We proudly partner with financial professionals and institutions to help individuals plan, save for and achieve secure financial futures. For more information, visit corebridgefinancial.com and follow us on LinkedIn.
Baltimore City Public Schools (City Schools) has selected Corebridge Financial as the sole provider for its supplemental retirement savings plans. By consolida
HOUSTON--(BUSINESS WIRE)--New research from Corebridge Financial reveals a retirement paradox: Even though fulfilling retirement dreams will likely require spending, many struggle with the thought of drawing down retirement savings to fund them. However, those with a decumulation plan have a much more positive outlook about retirement spending.
Only 28% of respondents are comfortable with the idea of their retirement savings declining to cover living expenses in retirement, and 70% say it is very important their nest egg does not shrink in retirement. Half associate retirement spending with “uncertainty” and 44% with “anxiety.”
A planning gap between the accumulation and decumulation phases of retirement may help explain this unease:
Just 14% of retirees say they have a detailed strategy to manage their Required Minimum Distributions. Only 29% of pre-retirees age 55 or older have a plan for retirement account withdrawals. “Retirement is meant to be enjoyed, but many find it difficult to give themselves permission to spend the savings they’ve worked so hard to build,” said Terri Fiedler, President of Retirement Services at Corebridge Financial. “Concerns about running out of money often shape spending habits that limit fulfillment later in life. Having a thoughtful decumulation strategy can help individuals manage complex financial decisions and feel more secure about the future.”
Fear of outliving savings may drive spending anxiety
When asked to choose, far more say they’d regret running out of money while still alive (56%) than dying with money left over (6%). Feeling financially secure is the top retirement goal for pre-retirees (85%) and retirees (82%).
This protectionist mindset may be leading to cautious spending behaviors: 38% of retirees say they have spent less than they wanted in order to maintain the size of their nest egg.
Surprisingly, retirees’ hesitation to spend is rarely driven by a desire to leave an inheritance: 83% do not have a specific inheritance goal and instead plan to leave behind whatever money is left over.
Planning and confidence are key to spending satisfaction
While many are uncomfortable drawing down savings in retirement, those who plan are more confident. Nearly 3 in 5 pre-retirees (57%) aged 55 or older who have a decumulation plan are highly confident they can manage spending throughout retirement, compared to 26% without a plan.
Similarly, 55% of retirees with a spending plan are highly confident, compared to only 29% without a plan.
Those who are highly confident they can manage their retirement spending are five times more likely to say spending in retirement is “empowering” (16% vs. 3%) and three times more likely to find it “rewarding” (20% vs. 6%) compared to those who lack confidence.
With 60% of respondents expecting to spend at least 20 years in retirement, and 45% expecting to live to age 90 or older, having the flexibility to confidently spend can enrich a long retirement. More than 6 in 10 associate retirement with “freedom” and “enjoyment.” Separate Corebridge research, “Living and Funding Longer Lives,” found that nearly 2 in 3 people see having more time to explore and experience new things as a benefit of living a very long life1—suggesting many hope to enjoy a retirement full of activities, which can often come with a price tag.
The most common approach to managing investments and spending in retirement cited by pre-retirees and retirees is using a consistent withdrawal percentage (e.g., the 4% rule).
“With fewer pensions, Social Security uncertainty and people living longer, it’s time to rethink how retirees transition from saving to spending,” continued Fiedler. “Previous strategies and rules of thumb may not cut it anymore. The new paradigm calls for a greater focus on guaranteed lifetime income.”
Enriching retirement with guaranteed income
Nearly 3 in 4 people believe having guaranteed lifetime income beyond Social Security, offered through solutions like annuities, would positively impact their ability to spend on things that make them happy.1
In fact, more respondents (47%) would prefer $60,000 per year guaranteed for life instead of a $1 million lump sum at age 65 (41%). And retirees say guaranteed lifetime income would enable them to spend more on personal fulfillment, including travel (69%), home improvements (29%) and dining out (25%).
Interest in guaranteed lifetime income from an annuity is strong with younger Gen Xers, who are most worried about their savings not lasting for life. Half of respondents ages 45–55 who are familiar with annuities said an annuity providing guaranteed lifetime income in retirement would be highly valuable.
This research is part of a wider campaign in collaboration with best-selling author and founder of HerMoney Jean Chatzky, to help people maximize their retirement security and enjoyment.
“For decades, retirement conversations have been focused on a singular financial challenge: Saving enough. It's a message Gen X, the first without pensions, took to heart and later generations followed,” said Chatzky. “But what's become evident as these folks start retiring is that without a plan of how to actually use that money, they face a retirement of uncertainty. Questions about how much you can spend, how well you can live, how much you can enjoy yourself and how long that money will last inevitably arise. Turning some of those hard-earned savings into a stream of income that lasts as long as you do can be a route to a more grounded, happier retirement all around.”
Visit our landing page for the full research findings, Corebridge’s new Decumulation Action Planner written by Jean Chatzky, and videos of Jean sharing real people’s stories on how they’re managing the shift from working and saving to spending and living in retirement.
About The Corebridge Financial Decumulation Planning Gap Study
The Decumulation Planning Gap Study was conducted for Corebridge Financial by Greenwald Research. Information was gathered through an online survey of 2,210 adults aged 45-79 who have $100,000 or more in investable assets. Surveys were completed between October 14, 2025, and November 3, 2025.
1Corebridge Financial Living and Funding Longer Lives, 2025
Annuities are long-term insurance products designed for retirement. Early withdrawals may be subject to withdrawal charges. Partial withdrawals reduce the contract value and may reduce certain benefits under the contract, such as the death benefit and the amount available upon full surrender. Withdrawals of taxable amounts are subject to ordinary income tax and, if taken prior to age 59½, an additional 10% federal tax may apply. Guaranteed lifetime withdrawal benefits and guaranteed living benefit riders may be optional or standard. Additional fees, age restrictions, withdrawal parameters, and other limitations apply.
All products and services are written or provided by subsidiaries of Corebridge Financial, Inc.
About Corebridge Financial
Corebridge Financial, Inc. (NYSE: CRBG) makes it possible for more people to take action in their financial lives. With more than $380 billion in assets under management and administration as of March 31, 2026, Corebridge Financial is one of the largest providers of retirement solutions and insurance products in the United States. We proudly partner with financial professionals and institutions to help individuals plan, save for and achieve secure financial futures. For more information, visit corebridgefinancial.com and follow us on LinkedIn.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOV.
[url="]Glancy Prongay Wolke and Rotter LLP[/url], a leading national shareholder rights law firm, today announced that it has commenced an investigation on behal
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In GE HealthCare (GEHC) To Contact Him Directly To Discuss Their Options
If you purchased or acquired stock in GE HealthCare and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.
Click here to participate in the action.
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) --
What’s Happening:
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC) on behalf of GE HealthCare stockholders. Our investigation concerns whether GE HealthCare has violated the federal securities laws and/or engaged in other unlawful business practices. Investigation Details:
On April 29, 2026, GE HealthCare announced its financial results for the first quarter of 2026. Among other disclosures, the Company reported adjusted earnings per share of $0.99, missing the consensus estimate of $1.05, and reduced its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00 from its prior guidance of $4.95 to $5.15. During the related earnings call, CEO Peter Arduini stated that “profitability in the first quarter was impacted by a PDx supplier issue that has since been resolved.” Following this news, the price of GE HealthCare shares fell by $9.01 per share, or approximately 13%, declining from $68.50 per share on April 28, 2026 to close at $59.49 per share on April 29, 2026. Next Steps:
If you purchased or otherwise acquired GE HealthCare shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]
What Happened?
On April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. Among other items, GE HealthCare reported adjusted earnings per share of $0.99, missing the consensus estimate of $1.05, and cut its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00, down from prior guidance of $4.95 to $5.15. CEO Peter Arduini said that “profitability in the first quarter was impacted by a PDx supplier issue that has since been resolved.” On this news, the price of GE HealthCare shares declined by $9.01 per share, or approximately 13%, from $68.50 per share on April 28, 2026 to close at $59.49 on April 29, 2026.
What Should I Do?
At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.
If you purchased or otherwise acquired GE HealthCare securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.
[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
The law firm of [url="]Kirby McInerney LLP[/url] continues its investigation on behalf of GE HealthCare Technologies Inc. (âGE HealthCareâ or the âCompan
NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]
What Happened?
On April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. Among other items, GE HealthCare reported adjusted earnings per share of $0.99, missing the consensus estimate of $1.05, and cut its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00, down from prior guidance of $4.95 to $5.15. CEO Peter Arduini said that “profitability in the first quarter was impacted by a PDx supplier issue that has since been resolved.” On this news, the price of GE HealthCare shares declined by $9.01 per share, or approximately 13%, from $68.50 per share on April 28, 2026 to close at $59.49 on April 29, 2026.
What Should I Do?
At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.
If you purchased or otherwise acquired GE HealthCare securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.
[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened.
[url="]Glancy Prongay Wolke and Rotter LLP[/url], a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technolo
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.
What Is The Investigation About?
On April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. Among other items, GE HealthCare reported adjusted earnings per share of $0.99 and cut its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00, down from prior guidance of $4.95 to $5.15.
During the associated earnings call, management disclosed “profit performance in the first quarter . . . was impacted by a recall associated with a PDx supplier” and that “[y]ear-over-year margin performance was also impacted by declines in PCS and the PDx supplier issue.”
On this news, the price of GE HealthCare shares declined by $9.01 per share, or 13.2%, to close at $59.49 per share on April 29, 2026.
Contact Us To Participate or Learn More:
If you purchased GE HealthCare securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Call us at: 310-914-5007
Email us at: [email protected]
Visit our website at: www.frankcruzlaw.com.
Follow us for updates on Twitter at twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
[url="]The Law Offices of Frank R. Cruz[/url] continues its investigation of GE HealthCare Technologies Inc. (âGE HealthCareâ or the âCompanyâ) (NASDAQ:
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
What Happened?
On April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. Among other items, GE HealthCare reported adjusted earnings per share of $0.99 and cut its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00, down from prior guidance of $4.95 to $5.15.
During the associated earnings call, management disclosed “profit performance in the first quarter . . . was impacted by a recall associated with a PDx supplier” and that “[y]ear-over-year margin performance was also impacted by declines in PCS and the PDx supplier issue.”
On this news, the price of GE HealthCare shares declined by $9.01 per share, or 13.2%, to close at $59.49 per share on April 29, 2026.
Contact Us To Participate or Learn More:
If you purchased GE HealthCare securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: [email protected],
Visit our website at: www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Key Takeaways GEHC launched a research collaboration with UW Medicine Radiology to advance CT and molecular imaging tech.Partnership aims automated workflows in cardiology, oncology and theranostics to speed clinical translation.Programs will build evidence for spectral imaging, AI protocols and oncology image-processing solutions. GE HealthCare Technologies Inc. (GEHC - Free Report) recently entered into a research collaboration with the University of Washington Department of Radiology (UW Medicine Radiology), focused on advancing computed tomography (“CT”) and molecular imaging (“MI”) technologies. The initiative aims to automate workflows across cardiology, oncology and theranostics while supporting faster clinical translation of next-generation imaging technologies.
Per management, molecular imaging and CT are converging more than ever to improve disease detection and characterization throughout the patient journey. The collaboration with UW Medicine Radiology will help to advance imaging technologies that provide more precise, actionable insights and support greater precision in diagnostic imaging innovation.
Likely Trend of GEHC Stock Following the NewsShares of GEHC have lost 0.2% since the announcement on Thursday. In the year-to-date period, shares of the company have fallen 21.7% compared with the industry’s 22.2% decline. However, the S&P 500 has risen 9.6% in the same timeframe.
In the long run, the collaboration strengthens GEHC’s position in advanced diagnostic imaging and precision medicine by deepening its 30-year relationship with UW Medicine Radiology. The partnership provides GEHC with a platform to refine and validate next-generation CT and molecular imaging technologies in real-world clinical settings, supporting broader adoption across global healthcare systems. The initiative also supports GEHC’s strategy of combining AI, automation and imaging hardware to improve workflow efficiency and deliver personalized patient care.
GEHC currently has a market capitalization of $29.22 billion.
Image Source: Zacks Investment Research
More on the Strategic CollaborationThe research collaboration between UW Medicine Radiology and GE HealthCare is focused on advancing CT, MI and theranostics to improve diagnosis, treatment and patient care. The partnership is built around two core programs aimed at accelerating innovation in imaging technologies and clinical workflows.
The CT program seeks to advance CT imaging science and clinical practice through research, collaboration and education. Key efforts include generating clinical evidence to support the adoption of spectral imaging technologies and improving CT workflows through automation and software tools that enhance efficiency for clinicians and patient experiences.
The MI and theranostics initiatives are designed to support personalized cancer care by integrating advanced diagnostic imaging, AI-enabled software and radiopharmaceuticals. The collaboration will focus on developing clinical evidence for innovative imaging protocols, applying deep learning to improve treatment planning and clinical trial matching, and creating advanced oncology imaging and image-processing solutions that enable precise, personalized care.
Industry Prospects Favoring the MarketGoing by the data provided by Mordor Intelligence, the U.S. diagnostic imaging market is valued at $10.57 billion in 2026 and is expected to witness a CAGR of 4.5% through 2031.
Factors like the AI-driven workflow and image interpretation, shift of imaging volumes to outpatient and ambulatory settings, rapid penetration of portable and handheld ultrasound/X-ray systems are driving the market’s growth.
Other NewsGE HealthCare recently announced a series of advancements in its next-generation SIGNA MR portfolio, including the FDA 510(k)-pending Sonic DL for faster AI-powered 2D imaging, the AI-enabled SIGNA One workflow ecosystem and the next-generation SIGNA Bolt 3T MRI system. The company also introduced the helium-free SIGNA Sprint with Freelium, expanded AIR Recon DL support for ZTE and Silenz imaging and launched SIGNA Studio research collaboration tools. In neuroscience, GE HealthCare announced new installations of its investigational MAGNUS head-only MR scanner at King’s College London and West China Hospital.
Some better-ranked stocks from the broader medical space are West Pharmaceutical (WST - Free Report) , Globus Medical (GMED - Free Report) and Intuitive Surgical (ISRG - Free Report) .
West Pharmaceutical, sporting a Zacks Rank #1 (Strong Buy) at present, reported first-quarter 2026 earnings per share (EPS) of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%. You can see the complete list of today’s Zacks #1 Rank stocks here.
West Pharmaceutical has an estimated long-term earnings growth rate of 13.9%. WST’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.4%.
Globus Medical, currently sporting a Zacks Rank #1, reported first-quarter 2026 adjusted EPS of $1.12, which surpassed the Zacks Consensus Estimate by 22.1%. Revenues of $759.9 million beat the Zacks Consensus Estimate by 4.0%.
Globus Medical has an estimated long-term earnings growth rate of 10.2%. GMED’s earnings beat estimates in each of the trailing four quarters, the average surprise being 26.3%.
Intuitive Surgical, carrying a Zacks Rank #2 (Buy) at present, reported first-quarter 2026 adjusted EPS of $2.50, which beat the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.
Intuitive Surgical has a long-term estimated growth rate of 14.6%. ISRG’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.
A month has gone by since the last earnings report for GE HealthCare Technologies (GEHC - Free Report) . Shares have added about 3.3% in that time frame, underperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is GE HealthCare due for a pullback? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for GE HealthCare Technologies Inc. before we dive into how investors and analysts have reacted as of late.
GEHC Q1 Earnings Miss Estimates, Revenues Beat, Net Margin DeclinesGE HealthCare Technologies reported first-quarter 2026 adjusted earnings per share of 99 cents, which missed the Zacks Consensus Estimate of $1.07 by 7.5%. Also, the bottom line declined 1.9% year over year.
GAAP earnings per share in the quarter was 85 cents, down 30.9% from the year-ago level.
GEHC’s Q1 Revenue DetailsRevenues of $5.13 billion were up 7.4% year over year on a reported basis and 2.9% organically. The top line beat the Zacks Consensus Estimate by 1.5%. Total company orders increased 1.1% year over year organically. The book-to-bill was 1.07X, reflecting rising orders compared to shipments.
Revenues were supported by strong performance in the United States, EMEA and Rest of World markets, primarily across three segments — Pharmaceutical Diagnostics (PDx), Imaging and Advanced Visualization Solutions (“AVS”) — partially offset by a decline in the Patient Care Solutions segment.
GE HealthCare’s Segmental DetailsImaging
Revenues from this segment totaled $2.29 billion, up 7.4% year over year on a reported basis and 3.8% organically.
Segment EBIT was $180 million, down 9.4% year over year.
Advanced Visualization Solutions
Revenues totaled $1.34 billion, up 8.2% year over year on a reported basis and 4.4% organically.
Segment EBIT was $299 million, up 14.5% year over year.
Patient Care Solutions
Revenues amounted to $704 million, down 6.5% year over year on a reported basis and down 8.1% organically.
Segment EBIT was $10 million, down 79.8% year over year.
Pharmaceutical Diagnostics
Revenues totaled $770 million, up 21.7% year over year and 9.7% on an organic basis.
Segment EBIT was $197 million, down 3.9% year over year.
GEHC’s Q1 Margin AnalysisNet income margin was 7.6%, down 420 basis points from the prior-year level due to the unfavorable impact of tariffs, a decline in Patient Care Solutions (PCS) and the PDx supplier issue.
Cumulative cash flow from operating activities at the end of the first quarter was $290 million compared with $250 million a year ago.
GE HealthCare’s Financial PositionGEHC exited the first quarter with cash, cash equivalents and investments of $2.28 billion compared with $4.51 billion in the previous quarter.
Total assets increased to $37.12 billion from $36.91 billion on a sequential basis.
GEHC’s 2026 GuidanceGE HealthCare updated its adjusted earnings per share guidance for 2026.
The company expects organic revenue growth of 3-4% in 2026. It anticipates adjusted earnings per share to be in the range of $4.80-$5.00, implying 4.6%-9.0% year-over-year growth. However, the guidance range is down from $4.95-$5.15, as expected previously. At current tariff rates, GEHC expects a lower impact in 2026 versus 2025.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -10.79% due to these changes.
VGM ScoresAt this time, GE HealthCare has a subpar Growth Score of D, a grade with the same score on the momentum front. However, the stock has a score of B on the value side, putting it in the second quintile for value investors.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise GE HealthCare has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
Performance of an Industry PlayerGE HealthCare is part of the Zacks Medical - Products industry. Over the past month, Zimmer Biomet (ZBH - Free Report) , a stock from the same industry, has gained 0.5%. The company reported its results for the quarter ended March 2026 more than a month ago.
Zimmer reported revenues of $2.09 billion in the last reported quarter, representing a year-over-year change of +9.3%. EPS of $2.09 for the same period compares with $1.81 a year ago.
Zimmer is expected to post earnings of $1.99 per share for the current quarter, representing a year-over-year change of -3.9%. Over the last 30 days, the Zacks Consensus Estimate has changed -2.3%.
Zimmer has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of C.